Logo
Home
Archive
Levity
About
Search
Login
Sign Up

Archive

Missed a briefing? Here you can find all our past issues.
Claude Mythos “routinely outperforms the best scientists out there”

Apr 12, 2026

•

15 min read

Claude Mythos “routinely outperforms the best scientists out there”

Plus: an AI that reads heart fat predicts failure five years out, Medra opens America's largest autonomous lab, and Genentech tests AI agents on 100 biology tasks.

Peter Ottsjö
Peter Ottsjö
8 things I learned when the biggest strategy report of 2026 turned to AI x bio

Apr 10, 2026

•

13 min read

8 things I learned when the biggest strategy report of 2026 turned to AI x bio

Amy Webb's Convergence Outlook devotes two of ten convergences to AI × bio. I read the 40+ pages so you don't have to.

Peter Ottsjö
Peter Ottsjö
OpenAI and Arc launch full-scale attack on Alzheimer's

Apr 9, 2026

•

12 min read

OpenAI and Arc launch full-scale attack on Alzheimer's

Plus: An AI designed enzymes for chemistry nature never invented, and a new study shows AlphaFold reversed a long-running decline in scientific novelty.

Peter Ottsjö
Peter Ottsjö
Anthropic spent $400M for a team with no product

Apr 5, 2026

•

13 min read

Anthropic spent $400M for a team with no product

Plus: A massive AI model predicts aging and a paper says AI can replace biological clocks.

Peter Ottsjö
Peter Ottsjö
Comparing AI x bio with quacks is not skepticism - it's just lazy

Apr 2, 2026

•

9 min read

Comparing AI x bio with quacks is not skepticism - it's just lazy

A Johns Hopkins professor says AI in biology is starting to look like pseudoscience. Here's what covering 60+ stories in the past six weeks have taught us.

Peter Ottsjö
Peter Ottsjö
The AI saw what the doctors missed

Apr 2, 2026

•

14 min read

The AI saw what the doctors missed

Plus: three ex-Ginkgo leaders argue biology needs its Bauhaus moment, and the LabOS team builds a simulation universe for AI agents.

Peter Ottsjö
Peter Ottsjö
Here's Lilly's $2.75 billion bet on AI-designed drugs

Mar 30, 2026

•

13 min read

Here's Lilly's $2.75 billion bet on AI-designed drugs

Plus: Meta open-sources a digital model of the brain, an AlphaFold veteran's agent designs drugs from a text prompt, and Anthropic may be building a biology mode.

Peter Ottsjö
Peter Ottsjö
Here's OpenAI's big bet on biology

Mar 25, 2026

•

13 min read

Here's OpenAI's big bet on biology

Plus: A $787 million AI biologics company emerges, and a multi-agent AI for dementia validated across 3 million patients.

Peter Ottsjö
Peter Ottsjö
This AI runs inside a chemical reaction (well, sort of)

Mar 22, 2026

•

13 min read

This AI runs inside a chemical reaction (well, sort of)

Plus: The field's own reality check, and experts preferred BioReason-Pro's reasoning over curated databases.

Peter Ottsjö
Peter Ottsjö
A virtual cell model just predicted biology it was never trained on

Mar 18, 2026

•

16 min read

A virtual cell model just predicted biology it was never trained on

Plus: NVIDIA breaks the size ceiling on protein folding, a million AI-designed proteins get tested in actual wet labs, and OpenClaw gets a science layer.

Peter Ottsjö
Peter Ottsjö
Load more

BAIO

The biggest tech story of the century.